Written by Partha Nandi, MD, FACP
A cancer cell doesn’t always start growing the moment it breaks away from a tumor. Sometimes it travels to a new organ, goes quiet, and sits there for years before it ever causes trouble. That silent phase is called cancer cell dormancy, and researchers at Mount Sinai’s Tisch Cancer Institute believe they’ve found one of the signals that keeps those cells asleep.
The signal is a protein you’ve probably heard of in the context of skin and joints: collagen. One form of it, called type III collagen. In mouse models and human tumor samples, the Mount Sinai team showed that when stray cancer cells are surrounded by plenty of type III collagen, they stay dormant. When that collagen thins out, the cells can wake up and begin to spread.
This is early science. It rests mostly on animal models and laboratory cell lines, and it isn’t a treatment you can ask for yet. What makes it worth your attention is the shift it suggests: the goal might one day move from destroying every last cancer cell to simply keeping the stragglers asleep.
Dr. Nandi’s Bottom Line
Type III collagen seems to help keep stray cancer cells dormant, and when it fades, those cells can wake up and spread. The evidence is still early, drawn from mice, cell lines, and tumor samples, so this is a research direction, not a treatment you can use. You can’t supplement your way to tumor-level collagen, and no habit keeps cancer asleep on command. What you can do is steady the conditions your cells live in and stay current on your screenings.
Understanding Metastasis
Most cancer deaths aren’t caused by the original tumor. They’re caused by metastasis, the spread of cancer cells to new parts of the body. The National Cancer Institute notes that metastases account for the majority of cancer-related deaths.
Metastasis starts when cells break away from the primary tumor and slip into the bloodstream or lymphatic system. A few of them survive the trip, settle in a distant organ, and face a hostile new environment. Many die. Some adapt.
The ones that adapt often do something clever: they go dormant. They stop dividing, dodge the immune system, and wait. This resting state can last months, years, or even decades. Because dormant cells grow slowly or not at all, standard treatments that target fast-dividing cells tend to miss them. That’s part of why a cancer can return long after someone was told they were in the clear.
Dormancy is also what makes these cells so hard to catch. A handful of quiet cells scattered across the body won’t show up on a scan. The question that has driven this field for years is easy to ask and hard to answer: what keeps these cells asleep, and what wakes them up?
What Makes Cancer Cells Dormant: The Role of Collagen
Part of the answer may come from the scaffolding around the cells. Every tissue sits in a mesh of proteins called the extracellular matrix, and collagen is its main building block. The Mount Sinai team, led by Jose Javier Bravo-Cordero, found that dormant cancer cells don’t just sit passively in this mesh. They remodel it, and they pack it with type III collagen.
Using high-resolution imaging to watch cells inside living mouse tissue, the researchers saw dormant cells build a type III collagen-rich niche around themselves. As long as that collagen stayed abundant and well organized, the cells stayed quiet. When the collagen thinned and its structure loosened, the cells switched back on and started to divide.
The signal runs through a receptor on the cancer cell called DDR1, which senses the collagen and triggers a downstream pathway (STAT1) that enforces the resting state. In plain terms, the collagen is talking to the cell, and the message is to stay put.
The human side of the study is correlational but telling. In tumor samples from patients with head and neck cancer, higher levels of type III collagen went along with disease that had not spread to the lymph nodes. Less spread, more of this collagen. That fits the dormancy story, though it doesn’t prove cause and effect in people.
Collagen keeps surfacing in dormancy research from more than one angle. If you want to go deeper on how the matrix around a cell shapes its behavior, I’ve written about another collagen study pointing in a similar direction.
Why Keeping Cancer Cells Dormant Is a Good Thing
For decades, the goal of cancer treatment has been to find and destroy every malignant cell. That’s hard, sometimes impossible, especially once cells have scattered. A dormancy-based approach flips the goal. Instead of chasing down every cell, it asks whether we can keep the dangerous ones locked in their sleep.
If that works, a few things follow:
- Fewer late relapses.Β Many cancers come back because a small number of cells survived treatment and reawakened later. Keeping them dormant could stretch out remission.
- Gentler on patients.Β Holding cells quiet may take less brute force than killing them, which could mean fewer side effects than aggressive treatment.
- Part of the toolkit.Β Dormancy strategies would likely work alongside surgery, chemotherapy, radiation, and immunotherapy, adding another layer to standard care rather than standing in for it.
None of this is on the shelf yet. The Mount Sinai researchers are clear that the near-term payoff is more likely a diagnostic, measuring collagen to flag recurrence risk, or a future drug that mimics the collagen signal. It’s one of several newer ideas aimed at managing cancer more cleverly, including efforts to coax cancer cells back toward a normal state.
What Wakes Dormant Cells Back Up: The Inflammation Link
If collagen helps hold cells asleep, what rouses them? This is where newer research gets interesting, and where it starts to connect to things you can influence.
In 2025, a team at MIT’s Whitehead Institute, led by Robert Weinberg, reported that inflammation can jolt dormant breast cancer cells awake. In their mouse experiments, inflammatory signals nudged quiet cells back into growth. More striking, once awakened, the cells kept an ‘awakening memory’ and no longer needed the inflammatory push to keep going.
That dovetails with how the National Cancer Institute now frames dormancy. Dormant cells live in a kind of truce with the surrounding tissue and the immune system. Immune cells, including natural killer cells, help keep stray cells in check, while the cancer cells try to ‘cloak’ and avoid detection. When that balance tips, through chronic inflammation, weakened immune surveillance, or changes in the local tissue, dormant cells can slip back into growth.
This is still early, animal-and-cell-level work, so I don’t want to oversell it. It does not mean an anti-inflammatory smoothie keeps cancer dormant. It does point in a sensible direction: the general state of your body, how inflamed it is and how well-defended, is part of the environment these cells sit in. Your gut plays a role here too, which I’ve looked at in how the bacteria in your gut influence your body’s cancer defenses.
My Personal RX on Creating an Internal Environment Where Cancer Struggles to Thrive
The idea that we might one day keep cancer cells asleep is exciting, and the research on collagen and the extracellular matrix is a good reminder that our cells are always responding to the conditions around them. Science is still working out exactly what rouses a dormant cell. In the meantime, a lot is already known about the daily habits that shape inflammation, immune function, and cellular health.
You don’t have to wait for the next breakthrough to start taking care of yourself. The tips below are the ones I come back to most with my patients: simple, sustainable practices that help build an internal environment where healthy cells can do well and rogue ones have a harder time getting a foothold.
- Eat for your own collagen, the right way.Β Your body builds collagen from vitamin C, zinc, copper, and amino acids like glycine and proline. Citrus, bell peppers, leafy greens, bone broth, and pumpkin seeds give it the raw materials for healthy skin, joints, and connective tissue.
- Make anti-inflammatory eating your baseline.Β Build meals around vegetables, fruit, legumes, whole grains, olive oil, and fatty fish. A steady anti-inflammatory pattern does more for your long-term health than any single so-called superfood.
- Fill the gaps with Super Greens.Β Even a solid diet can run short on the plant compounds that help your body handle everyday oxidative stress. A daily scoop ofΒ Super GreensΒ brings in a full-spectrum range of phytonutrients to round out what’s on your plate.
- Move most days.Β Regular activity improves circulation, supports lymphatic flow, and helps regulate the hormones and inflammatory signals tied to cellular health. Thirty minutes of brisk walking, strength work, or yoga most days is plenty.
- Follow a plan you can actually keep.Β Lasting change comes from a system, not a burst of willpower.Β Dr. Partha Nandi’s Protocol for Optimizing Your Health and WellbeingΒ lays out a holistic, step-by-step approach to the habits that keep your internal environment steady.
- Protect your sleep.Β Deep sleep is when your body does much of its cellular repair and immune housekeeping. Aim for 7 to 9 hours, keep the room cool and dark, and power down screens an hour before bed.
- Keep stress from running the show.Β Ongoing stress raises cortisol and inflammatory markers that can blunt immune surveillance. Daily breathing work, meditation, journaling, or time outdoors helps keep your nervous system out of constant fight-or-flight.
- Lower your everyday toxic load.Β Pesticide residue, harsh cleaning chemicals, and plastics can quietly add to inflammation and cellular stress. Choose organic where it counts, store food in glass or steel, and pick fragrance-free personal care products.
- Feed your gut, and the bacteria in it.Β Fiber feeds the microbes that make short-chain fatty acids, which help regulate inflammation body-wide. Aim for 30 or more different plant foods a week across vegetables, fruit, legumes, nuts, seeds, and whole grains.
- Stay in your screening and follow-up plan.Β Early detection is still one of our strongest tools. Keep up with the screenings recommended for your age and risk, and don’t brush off new or lingering changes in your body. Advocating for yourself is a health habit in its own right.
When to See a Doctor
Dormant cancer cells are, by definition, something you can’t feel or see, which is exactly why staying connected to your medical team is worth the effort. This isn’t about alarm. It’s about not ignoring signals that deserve a professional look, especially if you’ve been treated for cancer before.
Check in with your doctor if you notice:
- A lump or swelling that’s new, growing, or doesn’t go away.
- Unexplained weight loss, drenching night sweats, or ongoing fatigue.
- Pain that lingers for weeks without a clear cause, especially bone pain.
- A new cough, hoarseness, or shortness of breath that won’t quit.
- Changes in bowel or bladder habits, or bleeding where it shouldn’t happen.
- Any symptom that’s unusual for you and sticks around longer than a couple of weeks.
If you’re a cancer survivor, keep every scheduled follow-up and surveillance appointment, even when you feel well. Dormant disease doesn’t announce itself, so the monitoring plan your oncologist set is doing quiet, important work in the background.
References:
- Di Martino, J. S., Nobre, A. R., Mondal, C., Taha, I., Farias, E. F., Fertig, E. J., Naba, A., Aguirre-Ghiso, J. A., & Bravo-Cordero, J. J. (2022). A tumor-derived type III collagen-rich ECM niche regulates tumor cell dormancy.Β Nature Cancer, 3(1), 90β107. https://doi.org/10.1038/s43018-021-00291-9
- The Mount Sinai Hospital. (2021, December 13).Β Researchers discover how cells from tumors remain dormant for years before metastasis occurs.Β ScienceDaily. https://www.sciencedaily.com/releases/2021/12/211213111654.htm
- Zhang, J., et al. (2025). Inflammation awakens dormant cancer cells by modulating the epithelialβmesenchymal phenotypic state.Β Proceedings of the National Academy of Sciences, 122.Β https://doi.org/10.1073/pnas.2515009122
- National Cancer Institute. (2025, April 21).Β How do dormant cancer cells become metastases?Β Cancer Currents Blog. https://www.cancer.gov/news-events/cancer-currents-blog/2025/metastasis-dormant-cancer-cells-immune-system
- Park, S.-Y., & Nam, J.-S. (2020). The force awakens: Metastatic dormant cancer cells.Β Experimental & Molecular Medicine, 52(4), 569β581. https://doi.org/10.1038/s12276-020-0423-z
Frequently Asked Questions
Does eating collagen or taking collagen supplements keep cancer cells dormant?
No. The type III collagen in this research is produced by cells inside a tumor’s microenvironment, not absorbed from food or supplements. Dietary collagen supports skin, joints, and connective tissue, but there’s no evidence it affects dormant cancer cells. Don’t take collagen for that purpose.
Is this a cancer cure or a treatment I can get now?
Not yet. The work is based on mouse models, cell lines, and tumor samples. It points to possible future tools, like a test that measures collagen to gauge recurrence risk, or a drug that mimics the dormancy signal, but nothing is clinically available today.
What is type III collagen, and how is it different from regular collagen?
Collagen comes in several types. Type III is a fibrillar collagen found throughout the body’s connective tissue and in the matrix around cells. In this research, cancer cells build a type III collagen-rich scaffold around themselves that appears to help hold them in a resting, non-dividing state.
Can lifestyle choices keep cancer cells asleep?
No lifestyle choice can keep cancer cells dormant on command. What habits can do is support the broader environment, lower inflammation, a steadier metabolism, stronger immune function, that influences cellular health in general. They support your body; they don’t control dormancy, and they don’t replace medical care.
Which cancers has this been studied in?
The Mount Sinai team worked mainly with breast cancer and head and neck cancer in mouse models and cell lines, and analyzed tumor samples from head and neck cancer patients. Whether the same collagen mechanism holds across every cancer type is still being studied.











